JOSHUA LUMSDEN: Open Payments
NPI 1881062461 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$957 in 19 payments from 2 companies in 2025. Trend: 2023 $196 · 2024 $888 · 2025 $957
Food & beverage: $957
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 16 | $813 |
| ViiV Healthcare Company | 3 | $143 |
Products named: CABENUVA, Yeztugo, Biktarvy, DOVATO.
Industry payments across WA — which companies pay providers there.
